To study the effect of Akshitarpana and pana(oral intake) of Mahatriphaladi ghrita in Timira(simple myopia- far sightedness)

Further Study on Efficacy of Akshitarpan and pana of Mahatriphaladi Ghrita in the management of Timira(Simple myopia)-An Open Labelled Randomized Comparative Clinical Trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029217

Enrollment

Registered

2020-11-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H542- Low vision, both eyes

Interventions

Intervention1: Akshitarpana and pana with Mahatriphaladi Ghrita: In Group A patients will be given Mahatriphaladi ghrita for pana in approx. 5-10 ml dose alongwith Akshitarpana once a day for 21 days(

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient within the age group of 10-25 years with normal fundus will be included in the study. 2)Patients having signs and symptoms of Timira (Simple Myopia) described as per Ayurveda and Modern science. 3) Myopia upto-6D will be included in the study

Exclusion criteria

Exclusion criteria: 1)Patient below age of 10 years and above 25 years. 2)Patient having any other known ocular pathology eg. cataract, glaucoma, corneal opacity, and other retinal diseases. 3)Patient having myopia more than -6D. 4)Patient having myopic degenerative changes.

Design outcomes

Primary

Measure	Time frame
Changes in signs and symptoms of TimiraTimepoint: After 4 weeks of the trial	—

Secondary

Measure	Time frame
Improvement in Quality of life and social well being of patientTimepoint: After 4 weeks of the trial	—

Countries

India

Contacts

Public ContactDrDeepak Pawar

Institute for Post Graduate teaching and Research in Ayurveda

drdeep29@gmail.com7737379173

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026